🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Type 2 diabetes is the most common type of diabetes, affecting over 95% of people with diabetes worldwide, according to the World Health Organization (WHO). This condition occurs when the body fails to use insulin effectively. Previously considered a disease affecting adults over 40, type 2 diabetes is now increasingly diagnosed in younger individuals, even those in their 20s, largely due to stress and an inactive lifestyle.
Symptoms and Diagnosis
Type 2 diabetes often begins asymptomatically and symptoms develop slowly, making early diagnosis challenging. Common symptoms include:
Risk factors for type 2 diabetes include:
Diagnostic Tests:
Importance of Regular Health Check-ups
Once diagnosed, regular health check-ups are essential to monitor and manage diabetes. Uncontrolled diabetes can lead to complications affecting:
Management of Type 2 Diabetes
Management includes:
In cases of uncontrolled diabetes or high glucose levels, insulin injections or pens may be recommended by your doctor. It's crucial to adhere to the treatment plan and make lifestyle changes to effectively manage type 2 diabetes and prevent complications.
It is not known whether it is safe to consume alcohol with Semaglutide 0.25mg Subcutaneous Injection. Please consult your doctor for advice.
Semaglutide 0.25mg Subcutaneous Injection may be unsafe to use during pregnancy. Although limited human studies exist, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it. Please consult your doctor.
Information regarding the use of Semaglutide 0.25mg Subcutaneous Injection during breastfeeding is not available. Please consult your doctor.
It is not known whether Semaglutide 0.25mg Subcutaneous Injection alters the ability to drive. Do not drive or operate machinery if you experience any symptoms that affect your ability to concentrate and react.
Semaglutide 0.25mg Subcutaneous Injection is safe to use in patients with kidney disease. No dose adjustment is recommended.
Semaglutide 0.25mg Subcutaneous Injection is safe to use in patients with liver disease. No dose adjustment is recommended.
Semaglutide 0.25 mg/0.188 ml
Semaglutide 0.25mg Subcutaneous Injection contains Semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. GLP-1 agonists help to:
Adult Dose for Type 2 Diabetes Mellitus:
Hepatic Impairment: No dosage adjustment is required.
Child Dose:
Renal Dose:
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.